Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 16, 2024 08:00 ET | Source: Research Nester

Dietary Fibers Market revenue to surpass USD 15 Billion by 2035, says Research Nester

New York, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The global dietary fibers market size is predicted to expand at ~7% CAGR between 2023 and 2035. The market is projected to garner a revenue of USD 15...
March 22, 2022 09:31 ET | Source: Allied Market Research

Global Cell-Based Assay Market to Generate $26.34 Billion by 2030: Allied Market Research

Portland, OR, March 22, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Cell-Based Assay Market generated $11.74 billion in 2020, and is expected to...
March 19, 2014 13:09 ET | Source: Industry Standard Research

DCRI Receives Top Customer Loyalty Scores in ISR's 6th Annual CRO Quality Benchmarking Study

CARY, NC--(Marketwired - Mar 19, 2014) - Industry Standard Research (ISR) is announcing the launch of its 6th annual CRO Quality Benchmarking series with today's release of its "CRO Quality...
April 29, 2002 16:08 ET | Source: Women First HealthCare, Inc.

Women First HealthCare Reports First Quarter Profit of $0.01 Per Share vs. Loss of $0.05 Per Share in Prior Year; Revenue Up 33 Percent

SAN DIEGO, April 29, 2002 (PRIMEZONE) -- Women First HealthCare, Inc. (Nasdaq:WFHC) today announced a first quarter 2002 profit of $243,000, or $0.01 per fully diluted share, on total revenues of...
October 26, 2001 12:48 ET | Source: Competitive Technologies, Inc.

Competitive Technologies Licensee Presents PT-141 Data

FAIRFIELD, Conn., Oct. 26, 2001 (PRIMEZONE) -- Competitive Technologies, Inc. (AMEX:CTT) announced today that scientists at its exclusive licensee Palatin Technologies, Inc. (AMEX:PTN), in...
September 25, 2001 13:29 ET | Source: Competitive Technologies, Inc.

Competitive Technologies Licensee Begins New Cancer Trial

FAIRFIELD, Conn., Sept. 25, 2001 (PRIMEZONE) Competitive Technologies, Inc. (AMEX:CTT) reported today that its licensee, Ribozyme Pharmaceuticals Inc. (Nasdaq:RZYM) announced the start of the third...